- Expanding roles for atorvastatin
[作者:Singh, V; Deedwania, P,期刊:Drugs of today, 页码:455-471 , 文章类型: Article,,卷期:2008年44-6]
Atherosclerosis, especially when manifested as coronary artery disease (CAD), continues to be the number one cause of mortality and morbidity in developed nations and will soon become so in developing countries. Survi...
- Armodafinil for excessive daytime sleepiness
[作者:Nishino, S; Okuro, M,期刊:Drugs of today, 页码:395-414 , 文章类型: Article,,卷期:2008年44-6]
Armodafinil is the (R)-enantiomer of the wake-promoting compound modafinil (racemic), with a considerably longer half-life of 10-15 hours. Armodafinil (developed by Cephalon, Frazer, PA, USA) was approved in June 2007...
|